Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Head-to-Head Comparison of [68Ga]Ga-PSMA-11 PET Interpreted with Non-Contrast CT Versus Excretory-Phase CT Urography in Biochemical Recurrence of Prostate Cancer.

Cancers·2026
Same author

Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.

Signal transduction and targeted therapy·2025
Same author

An MRI/PET PSMA-based phase I-II study of salvage high-dose-rate brachytherapy after surgery and radiotherapy.

BJU international·2025
Same author

Prospective Registry Trial of Adjuvant High-Dose Rate Brachytherapy in Unirradiated Head and Neck Cancer: 20-Year Data.

Head & neck·2025
Same author

Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023

Related Experiment Video

Updated: Aug 12, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K

ENPP1 Immunobiology as a Therapeutic Target.

Borja Ruiz-Fernández de Córdoba1, Rafael Martínez-Monge2,3,4, Fernando Lecanda1,4,5,6

  • 1Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Navarra, Spain.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 31, 2023
PubMed
Summary

Ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) overexpression fuels tumor growth and immune suppression. Blocking ENPP1 may restore anti-tumor immunity and improve cancer treatment outcomes.

More Related Videos

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
09:45

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

2.1K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.4K

Related Experiment Videos

Last Updated: Aug 12, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K
Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
09:45

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

2.1K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

9.4K

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) is implicated in physiological processes but frequently overexpressed in solid tumors, correlating with metastasis and poor prognosis.
  • ENPP1 contributes to an immunosuppressive tumor microenvironment (TME) by modulating ATP/adenosine balance and interfering with the stimulator of interferon genes (STING) pathway.
  • Hydrolysis of 2´,3´-cyclic GMP-AMP by ENPP1 impairs robust immune responses, highlighting its role in immune evasion.

Approach:

  • This review summarizes current research on ENPP1's role in cancer immunity.
  • It explores the therapeutic potential of ENPP1 blockade in combination with other modalities.
  • The review discusses novel treatment strategies targeting ENPP1 for improved clinical outcomes.

Key Points:

  • ENPP1 blockade is a promising strategy for immune remodeling and leveraging the STING pathway.
  • ENPP1 inhibitors demonstrate immunostimulatory effects.
  • Combinations of ENPP1 inhibitors with immune-checkpoint blockade, STING activators, DDR inhibitors, or radiotherapy show potential for enhancing anti-tumor immunity.

Conclusions:

  • Targeting ENPP1 offers a unique approach to overcome tumor-induced immunosuppression.
  • ENPP1 inhibition can synergize with various therapeutic strategies to boost anti-tumor immune responses.
  • Further research into ENPP1 blockade holds promise for improving cancer treatment outcomes.